Stay updated on Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page.

Latest updates to the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe history adds a new revision entry (v3.3.3) and removes HHS Vulnerability Disclosure and Revision: v3.3.2, affecting only the page metadata rather than the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedAdded Revision: v3.3.1 and removed the notices about funding lapse and the earlier Revision: v3.2.0 as part of the page history. These are administrative backend updates that do not affect the study data, eligibility, or results on the NCT02329327 record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check61 days agoChange DetectedThe Old and New screenshots show the same version history entries with only minor UI spacing and label adjustments, not affecting content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference11%

- Check97 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check111 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, indicating a minor release; the Back to Top link was removed.SummaryDifference0.6%

Stay in the know with updates to Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa Reversal in Bleeding: Anticoagulant Clinical Trial page.